30
CARDIOVASCULAR
hamburger

Re-imagine PCI with Ultreon™ 1.0 Software

Streamlined and intuitive, Ultreon™ 1.0 Software gives better insights to optimize patient outcomes through automation and an improved workflow.1-4

  • Ultreon™ Software allows interventional cardiologists to see inside the heart during percurtenous coronary intervention (PCI) and act on the obtained insights.

  • Ultreon™ Software guides physicians through PCI step-by-step following MLD MAX workflow and provides insights on morphology, vessel sizing, stent placement and post-stent optimization for more accurate decision-making.1

  • Ultreon™ Software is powered by artificial intelligence (AI) that enables automatic quantification of calcification and vessel sizing.1

  • WATCH PCI LIVE CASE WITH ULTREON 1.0 SOFTWARE

"It was worth the wait. I can see you have developed something that is really user-friendly, which was the main intent." — Pr. Souteyrand

Ultreon™ Software: The Next-Generation Imaging and Physiology Platform

See Simply & Act Decisively During PCI with Ultreon™ Software

See Simply

The Ultreon™ Software with an intuitive interface offers physicians a user-friendly on-screen information and step-by-step guidance following MLD MAX workflow to aid with decision-making;5 to determine a proper treatment technique pre-PCI and to ensure optimal stent expansion results post-PCI.
 

Ultreon™ 1.0 Software intuitive workflow interface - 1
Ultreon™ 1.0 Software intuitive workflow interface - 1
Ultreon™ 1.0 Software intuitive workflow interface - 2
Ultreon™ 1.0 Software intuitive workflow interface - 2
Morphology
Morphology screen displaying angle and max thickness of calcification
Morphology screen displaying angle and max thickness of calcification

Ultreon™ 1.0 Software uses artificial intelligence (AI) to automatically detect degree and thickness of calcification.1

  • Auto-detects and highlights calcification arc and max thickness6
  • Displays calcification angle and max thickness values throughout the pullback in real-time6
  • Highlights calcification overlays on the vessel with the co-registration view6
Sizing
Sizing screen displaying External Elastic Lamina (EEL) and Lumen diameter for proximal, current and distal frames
Sizing screen displaying External Elastic Lamina (EEL) and Lumen diameter for proximal, current and distal frames

Ultreon™ 1.0 Software uses artificial intelligence (AI) to automatically detect external elastic lamina (EEL) and lumen to help identify landing zones for accurate stent placement.1,7

  • Provides vessel diameter measurements6
  • Facilitates measuring lesion length and identification of optimal user-adjusted stent landing zones on a single screen6
  • Autodetects and provides measurement of lumen and detectable external elastic lamina (EEL) for quick visualization6
  • Facilitates stent length selection through co-registration6

Act Decisively

Deployment

Ultreon™ Software provides side-by-side viewing of live and co-registered angio to help physicians guide precise stent deployment.6

  • Helps to ensure complete lesion coverage and avoid stent edges in high-risk morphology8
Ultreon™ 1.0 Software interface for stent deployment
Ultreon™ 1.0 Software interface for stent deployment
Review

Ultreon™ Software helps to ensure optimal stent expansion and apposition with instantaneous display of expansion and apposition results.6

Ultreon™ 1.0 Software interface for review assessment
Ultreon™ 1.0 Software interface for review assessment
 

Watch OCT-Guided PCI Live Case With Ultreon™ Software

In this PCI case of a calcified lesion presented at EuroPCR2021, the expert panel discusses when to use physiology and when to use imaging during PCI, and how these tools can guide and support the procedure. During the case, the physicians use Ultreon™ Software that’s enabled by AI, to showcase its features such as automatic calcium detection, automatic EEL detection, live angio co-registration and more.

In this complex PCI case of a long diffuse LAD lesion, the expert panel discusses how physiology and OCT imaging pre and post-PCI can guide and support treatment. During the case, the physicians use PressureWire™ X Guidewire for physiology assessment and the brand new Ultreon™ Software that’s enabled by AI for intravascular imaging. Physicians showcase its features such as automatic calcium detection, automatic EEL detection, and how to perform PCI following
MLD MAX algorithm.

References

* Compared to AptiVue™ Imaging Software

  1. Data on file at Abbott.
  2. Zhang J, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126-3137. doi: 10.1016/j.jacc.2018.09.013.
  3. Hong M, et al. IVUS-XPL 5 Year Outcomes, TCT 2019.
  4. Jones et al. JACC Cardiovascular Interventions, 2018, vol 11 (14). “Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention – Outcomes From the Pan-London PCI Cohort”.
  5. Bezerra H, et al. Analysis of changes in decision-making process during optical coherence tomography-guided percutaneous coronary interventions: Insights from the LightLab Intiative. EuroPCR 2020.
  6. Ultreon™ 1.0 Software IFU. Refer to Instructions For Use (IFU) for additional information.
  7. Prati, F. et al. The CLI-OPCI II Study. JACC: Cardiovascular Imaging, 2015: Vol 8, No. 11:1297-305.
  8. Kubo T, et al. Application of optical coherence tomography in percutaneous coronary intervention. Circ J. 2012;76(9):2076-2083. doi: 10.1253/circj.cj-12-0828.

MAT-2102546 v3.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.